Press releases

Un biomarqueur, pronostic de l’évolution du cancer du poumon

Press release | 01 Sep 2010 - 15h20 | By INSERM PRESS OFFICE
Cancer | Circulation, metabolism, nutrition
TO CITE THIS POST :
Press release – Inserm press room Un biomarqueur, pronostic de l’évolution du cancer du poumon Link : https://presse.inserm.fr/en/francais-un-biomarqueur-pronostic-de-levolution-du-cancer-du-poumon/14938/
Medias
Researcher Contact

Patricia Forgez Inserm UPMC U938 Hôpital Saint-Antoine 184 rue du Fbg Saint-Antoine 75571 Paris 12, France Tél. : 01 49 28 46 74

Sources

"Neurotensin Receptor 1 Determines the Outcome of Non–Small Cell Lung Cancer" Marco Alifano1, Frédérique Souazé3, Sandra Dupouy2, Sophie Camilleri-Broët4, Mohamad Younes2, Sadi-Menad Ahmed-Zaïd2, Takashi Takahashi5, Alessandra Cancellieri6, Stafania Damiani7, Maurizio Boaron7, Philippe Broët4, Lance D. Miller8, Christian Gespach2, Jean François Regnard1, and Patricia Forgez2 1. Service de chirurgie thoracique, Hôtel-Dieu 2. Inserm-UPMC U 938, Paris, France 3. EA-4273 Biometadys, Faculté de Médecine, Nantes, France 4. JE2492, Université Paris-Sud, Villejuif, France 5. Center for Neurological Diseases and Cancer, Nagoya, Japan 6. Pathology Department 7. Thoracic Surgery Department, Maggiore-Bellaria Hospital, Bologna, Italy 8. Wake Forest University School of Medicine, Medical Center, North Carolina Clinical Cancer Research 1er septembre 2010

fermer
fermer
RSS Youtube